$ENZ to $2.94 LONG - Monthly setup is strong
3/16/23 - Enzo Biochem (ENZ) stock is rising higher on an asset sale agreement.
It’s selling its Clinical Laboratory division to Labcorp (LH).
3/20/23 - Monthly GD on MC.
8/23/23 - $3 per share.
It’s selling its Clinical Laboratory division to Labcorp (LH).
3/20/23 - Monthly GD on MC.
8/23/23 - $3 per share.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.